Trade receivables increased 40.1%
Trade receivables changed +40.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
$15.7B→$22.0B8 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CVX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 305 bp higher
Working capital / assets changed +305 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-0.05%→3.00%4 prior comparisons
Shares outstanding increased 14.3%
Shares outstanding changed +14.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
1,727,990,376→1,975,771,2748 prior comparisons
Net income increased 384.8%
Net income changed +384.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.5B→$12.1B2 prior comparisons
Current ratio increased 25.7%
Current ratio changed +25.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1→1.254 prior comparisons
Revenue increased 51.4%
Revenue changed +51.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$44.4B→$67.2B2 prior comparisons
Inventory increased 19.4%
Inventory changed +19.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.8B→$10.5B4 prior comparisons
Free-cash-flow proxy increased 272.0%
Free-cash-flow proxy changed +272.0% from the comparable as-filed period.
$4.9B→$18.1B3 prior comparisons
Operating cash flow increased 163.9%
Operating cash flow changed +163.9% from the comparable as-filed period.
$8.6B→$22.6B3 prior comparisons
Working capital changed across a sign change
Working capital changed +7375.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$136.0M→$9.9B4 prior comparisons
Gross margin moved 605 bp higher
Gross margin changed +605 basis points from the comparable as-filed period.
39.47%→45.52%2 prior comparisons
Inventory / revenue moved 420 bp lower
Inventory / revenue changed -420 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
19.86%→15.66%2 prior comparisons
Cost of revenue increased 36.3%
Cost of revenue changed +36.3% from the comparable as-filed period.
$26.9B→$36.6B2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.